TCL Archive NCI Advisors Criticize a Biomarker Study Touted as High Priority for NCI and FDA. July 13, 2007
TCL Archive After Aggressive Budgetary Trimming, At $33 Million NCI’s caBIG Remains Big December 2, 2011